Adocia SA (EPA:ADOC)
3.910
-0.050 (-1.26%)
Aug 3, 2026, 12:35 PM CET
Adocia Market Cap
Adocia has a market cap or net worth of €77.48 million as of August 3, 2026. Its market cap has decreased by -36.59% in one year.
Market Cap
77.48M
Enterprise Value
69.13M
Revenue
3.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.91
ChartMarket Cap Chart
Since February 20, 2012, Adocia's market cap has decreased from 93.74M to 77.48M, a decrease of -17.34%. That is a compound annual growth rate of -1.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 77.48M | -40.86% |
| Dec 31, 2025 | 131.01M | 40.99% |
| Dec 31, 2024 | 92.92M | -42.69% |
| Dec 29, 2023 | 162.13M | 379.37% |
| Dec 30, 2022 | 33.82M | -41.93% |
| Dec 31, 2021 | 58.24M | 1.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Transgene | 194.73M |
| Cellectis | 179.18M |
| Sensorion | 146.18M |
| Innate Pharma | 143.70M |
| OSE Immunotherapeutics | 75.41M |
| ABIONYX Pharma | 65.50M |
| THX Pharma Société Anonyme | 59.33M |
| MaaT Pharma | 52.39M |